Home › Chronic Kidney Disease › Nebraska
Chronic Kidney Disease clinical trials in Nebraska
3 studies for Chronic Kidney Disease are looking for participants at sites in Nebraska.
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- University of Nebraska Medical Center, Omaha
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 11, 2026 · NCT07271186Empagliflozin Treatment in Kidney Transplant Recipients
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
RecruitingPhase 4
Ages 19 and older · All sexes · Updated Apr 21, 2026 · NCT06013865From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.